Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00451724
Other study ID # 0014-07
Secondary ID
Status Completed
Phase Phase 2
First received March 21, 2007
Last updated July 21, 2010
Start date May 2007
Est. completion date February 2010

Study information

Verified date July 2010
Source Rhode Island Hospital
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The purpose of this study is to compare how well three different doses of ketamine, given as a spray into the nose, help to sedate children and help them tolerate repairs of cuts on their faces.


Description:

Procedural sedation is frequently used to facilitate distressing and painful procedures in the pediatric emergency department. However, administering an intramuscular medication or placing an intravenous line to give intravenous medications can be as distressing as the procedure itself. Oral medications generally take longer to work and are subject to first-pass metabolism. Another alternative is to give the medication by the intranasal route, which only requires a spray into the nose. Ketamine is a good sedative drug with favorable qualities, and is often used intramuscularly or intravenously. It has been used intranasally as a pre-induction by anesthetics, sedation for CT scans, and brief dental procedures, but its use has not yet been demonstrated in the setting of the pediatric emergency department for procedural sedation. We will be comparing three different doses of ketamine, applied intranasally using a mucosal atomization device, and determining if there are any differences in efficacy of sedation, time to onset of sedation, duration of sedation, caregiver and physician satisfaction, and number of adverse events. We will also use this opportunity to determine ketamine bioavailability when given intranasally using the mucosal atomization device.


Recruitment information / eligibility

Status Completed
Enrollment 45
Est. completion date February 2010
Est. primary completion date
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 1 Year to 7 Years
Eligibility Inclusion Criteria:

- Children between 1 to 7 years old

- Simple facial laceration, defined as: linear; requiring two or more sutures; no greater than 5.0 centimeters; does not cross the lid margin of the eye; does not require a plastics/face surgery consult; occured within the last 24 hours.

- Physician feels that intravenous sedation is required to perform the laceration repair

Exclusion Criteria:

- Closed head injury, any alteration in level of consciousness, clinical suspicion of intracranial injury or increased intracranial pressure

- Any conditions that qualify patient as American Society of Anesthesiologists' (ASA) III or IV

- Known diagnoses of hyperthyroidism or porphyria

- Glaucoma or penetrating eye injury

- Hypertension

- Any contraindication, including drug allergy, to study medications

- Severe trauma with other injuries requiring operative intervention

- Abnormal neurological exam in a previously normal child

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
Intranasal ketamine


Locations

Country Name City State
United States Hasbro Children's Hospital Providence Rhode Island

Sponsors (1)

Lead Sponsor Collaborator
Rhode Island Hospital

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Efficacy of sedation (OSBDR) 30 minutes
Primary Time to onset of sedation (Ramsay 6-point Sedation Scale) 30 minutes
Secondary Duration of sedation Up to 1 hour
Secondary Primary caregiver satisfaction 24 hours
Secondary Physician satisfaction Duration of procedure
Secondary Ketamine bioavailability 1 hour
Secondary Abnormalities in cardiopulmonary function Until time of discharge
Secondary Administration of supplemental sedative medication During time required for procedure
Secondary Prolonged sedation (i.e. > 1 hour) Until time of discharge from emergency department
See also
  Status Clinical Trial Phase
Terminated NCT03280628 - Trial Comparing Cosmetic Outcomes of Pediatric Laceration Closure Using Skin Glue, Medical Tape Versus Stitches N/A
Completed NCT05240248 - Optilene® Suture Material for Dermal Sutures
Completed NCT02882256 - Video Discharge Instructions (VDI) as Adjuncts to Written Discharge Instructions in the Emergency Department N/A
Active, not recruiting NCT02168439 - Intranasal Dexmedetomidine vs Intranasal Midazolam as Anxiolysis Prior to Pediatric Laceration Repair Phase 4
Completed NCT03199456 - A Randomized Post-market Study to Evaluate Zip Device Compared to Sutures for Laceration Repair in Pediatrics and Adults N/A
Completed NCT03080467 - Long-Term Outcome of Pediatric Traumatic Wound Repair: Suture Versus Tissue Adhesive
Recruiting NCT05225714 - Dermal Wound Closure Using Silkam®
Active, not recruiting NCT01911351 - Nitrous Oxide Use in Minor Procedures N/A
Suspended NCT01268670 - The Addition of Oral Analgesics to LET During Laceration Repair N/A
Recruiting NCT04557761 - Comparison of microMend® Devices to Sutures in Closing Lacerations in Children N/A
Completed NCT05812352 - Supporting Laypeople Addressing Prehospital Hemorrhage Study N/A
Completed NCT00834730 - Comparison of N2O Inhalation and Ketamine in Pediatric PSA Phase 4
Completed NCT03053947 - Pain Free Laceration Repairs Using Intra-nasal Ketamine Phase 2
Recruiting NCT03681717 - Virtual Reality vs. Standard-of-Care for Comfort During Laceration Repair N/A
Completed NCT03071601 - Prospective Evaluation of Topical Analgesia for Laceration Repair in the Emergency Department Phase 4
Completed NCT06370910 - Comparison Low-Level Laser Therapy With Cryotherapy in Parturients With Laceration and/or Episiotomy on Pain Reduction N/A
Completed NCT05148390 - Study to Examine Clinical Performance and Safety of Cutimed® Gelling Fiber in Routine Clinical Practice
Not yet recruiting NCT06217081 - 3M™ Topical Tissue Adhesive Versus Commercially Available Tissue Adhesive for the Closure of Lacerations and Incisions N/A
Withdrawn NCT03499002 - Teaching Medical Students How to Suture: Standard Simulation vs in Situ N/A